| dbo:abstract
|
- بروميد الأوميكليدينيوم/فيلانتيرول (الاسم التجاري: Anoro Ellipta) هو توليفة دوائية مرخصة لعلاج داء الانسداد الرئوي المزمن. يستعمل عن طريق الاستنشاق. (ar)
- Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It is administered by inhalation. The most common side effects include upper respiratory tract infections (nose and throat infection), urinary tract infections (infection of the structures that carry urine), pharyngitis (inflammation of the throat), sinusitis (inflammation of the sinuses), nasopharyngitis (inflammation of the nose and throat), headache, cough, oropharyngeal pain (pain in the mouth and throat), constipation and dry mouth. In 2020, it was the 254th most commonly prescribed medication in the United States, with more than 1 million prescriptions. (en)
|
| dbo:alternativeName
|
- Anoro Ellipta, Laventair Ellipta (en)
|
| dbo:casNumber
| |
| dbo:kegg
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4386 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:atcSuffix
| |
| dbp:caption
|
- Umeclidinium bromide , vilanterol (en)
|
| dbp:casNumber
| |
| dbp:class
| |
| dbp:component
|
- Umeclidinium bromide (en)
- Vilanterol (en)
|
| dbp:dailymedid
| |
| dbp:kegg
| |
| dbp:legalEu
| |
| dbp:legalUk
| |
| dbp:legalUs
| |
| dbp:licenceEu
| |
| dbp:pregnancyAu
| |
| dbp:routesOfAdministration
| |
| dbp:tradename
|
- Anoro Ellipta, Laventair Ellipta (en)
|
| dbp:type
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- بروميد الأوميكليدينيوم/فيلانتيرول (الاسم التجاري: Anoro Ellipta) هو توليفة دوائية مرخصة لعلاج داء الانسداد الرئوي المزمن. يستعمل عن طريق الاستنشاق. (ar)
- Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It is administered by inhalation. In 2020, it was the 254th most commonly prescribed medication in the United States, with more than 1 million prescriptions. (en)
|
| rdfs:label
|
- بروميد الأوميكليدينيوم/فيلانتيرول (ar)
- Umeclidinium bromide/vilanterol (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
